Updated Jul 16, 2026
Lalwani Nikhil has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $11.10M.

Nikhil Lalwani is the President and CEO of ANI Pharmaceuticals Inc, a company that specializes in the development and manufacturing of generic prescription pharmaceuticals. He has been instrumental in leading the company through its growth and product development initiatives.
| Role | PRESIDENT & CEO, Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 55.0K | $77.57 | $4.27M |
| 2026-03-10 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 17.1K | $74.04 | $1.26M |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 12.2K | $73.90 | $903K |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 75.6K | $77.15 | $5.83M |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 10.3K | $77.36 | $797K |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 11.7K | $76.70 | $896K |
| 2026-02-13 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 30.7K | $76.25 | $2.34M |
| 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 57.0K | $85.93 | $4.89M |
| 2024-11-27 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 3.5K | $58.30 | $203K |
| 2024-11-27 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 30.0K | $57.95 | $1.74M |
| 2024-11-27 | ANIP | ANI PHARMACEUTICALS INC | M — Option exercise | 30.0K | $29.00 | $870K |
Nikhil Lalwani is the President and CEO of ANI Pharmaceuticals Inc, a company that specializes in the development and manufacturing of generic prescription pharmaceuticals. He has been instrumental in leading the company through its growth and product development initiatives.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($11.10M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lalwani Nikhil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.